Evidence map›Paper›PMID 42494400›Full record

ArticleFrontiers in neurology

Circular RNA circNUP214 serves as a microRNA-31 sponge to promote the progression of myasthenia gravis through NFAT5.

Fanfan Xu, Xiaotong Kong, Shanshan Peng, Lifang Li, Wenqi Tian, Hanlu Cai, Yichen Li, Ying Li, Jingyan Niu, Nan Zhang and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fanfan Xu *Department of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiaotong Kong *Department of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Shanshan PengDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Lifang LiDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Wenqi TianDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Hanlu CaiDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yichen LiDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Ying LiDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Jingyan NiuDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Nan ZhangDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Huixue ZhangDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Lihua WangDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myasthenia gravis (MG) is an autoimmune disease driven by autoantibodies targeting the neuromuscular junction, leading to muscle weakness. Although emerging evidence implicates circular RNAs (circRNAs) in MG, their specific regulatory mechanisms remain largely unknown. In particular, the role of circNUP214 in MG has not been characterized. CircNUP214 expression in PBMCs and CD4

Indexed as

ceRNAcircNUP214circular RNAmyasthenia gravisNFAT5

Identifiers

PMID42494400
PMCPMC13391849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.